Profile data is unavailable for this security.
About the company
Euroapi SAS is a France-based company. The Company is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. It offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. The Company also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. It has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
- Revenue in EUR (TTM)882.80m
- Net income in EUR-124.30m
- Incorporated2020
- Employees3.43k
- LocationEuroapi SA15, rue TraversierePARIS 75012FranceFRA
- Phone+33 189206200
- Websitehttps://www.euroapi.com/en
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valerio Therapeutics SA | 1.83m | -13.17m | 75.67m | 25.00 | -- | -- | -- | 41.35 | -0.0914 | -0.0914 | 0.012 | -0.0591 | 0.0735 | -- | 0.4026 | 48,157.89 | -52.95 | -33.39 | -145.21 | -42.47 | 59.34 | 78.97 | -720.27 | -631.62 | -- | -17.09 | -- | -- | -0.3889 | -16.01 | -17.57 | -- | 65.11 | -- |
| AB Science SA | 1.03m | -8.54m | 84.98m | 37.00 | -- | -- | -- | 82.75 | -0.1478 | -0.1478 | 0.0178 | -0.457 | 0.0465 | 0.4429 | 7.93 | 26,333.33 | -38.64 | -52.12 | -206.63 | -332.22 | 90.75 | 93.25 | -831.45 | -1,016.80 | 0.668 | -4.96 | -- | -- | 10.52 | -7.36 | 34.66 | -- | -16.85 | -- |
| Euroapi SA | 882.80m | -124.30m | 214.12m | 3.43k | -- | 0.2237 | -- | 0.2426 | -1.31 | -1.31 | 9.33 | 10.01 | 0.5453 | 1.29 | 5.67 | 257,526.30 | -7.68 | -4.32 | -11.36 | -5.77 | 13.71 | 14.37 | -14.09 | -7.36 | 0.7994 | -1.65 | 0.0671 | -- | -9.79 | 0.0741 | 31.15 | -- | 5.71 | -- |
| Boiron SA | 504.86m | 19.37m | 489.52m | 2.74k | 25.01 | 1.31 | 7.98 | 0.9696 | 1.12 | 1.12 | 29.08 | 21.26 | 0.9021 | 1.30 | 6.51 | 182,193.40 | 3.46 | 4.01 | 4.34 | 5.04 | 73.71 | 73.23 | 3.84 | 5.81 | 1.46 | -- | 0.0467 | 66.42 | -1.15 | -2.63 | -68.36 | -22.53 | -15.75 | 2.71 |
| Medincell SA | 28.41m | -19.95m | 803.46m | 145.00 | -- | -- | -- | 28.28 | -0.6143 | -0.6143 | 0.8982 | -0.9254 | 0.4258 | -- | 28.18 | 202,907.10 | -29.90 | -51.18 | -50.21 | -133.26 | 56.60 | 82.68 | -70.22 | -210.68 | -- | -0.9935 | 2.11 | -- | 181.43 | 54.88 | 26.36 | -- | 13.30 | -- |
| DBV Technologies SA | 3.23m | -104.02m | 974.69m | 109.00 | -- | 6.63 | -- | 302.21 | -0.9587 | -0.9587 | 0.0298 | 0.535 | 0.0295 | -- | 0.2091 | 29,320.46 | -95.23 | -53.19 | -135.74 | -65.71 | -- | 92.99 | -3,225.05 | -1,296.09 | -- | -172.41 | 0.082 | -- | -73.61 | -22.35 | -56.96 | -- | -16.00 | -- |
| Vetoquinol SA | 532.39m | 59.96m | 1.03bn | 2.50k | 17.07 | 1.81 | 12.19 | 1.94 | 5.10 | 5.10 | 45.25 | 48.20 | 0.7434 | 2.00 | 5.83 | 212,870.50 | 8.37 | 7.52 | 10.34 | 9.96 | 53.16 | 61.63 | 11.26 | 9.54 | 2.13 | -- | 0.0303 | 16.72 | 1.88 | 6.37 | 5.62 | 15.47 | 4.29 | 18.56 |
Data as of Feb 19 2026. Currency figures normalised to Euroapi SA's reporting currency: Euro EUR
22.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brandes Investment Partners LPas of 22 Jul 2025 | 4.90m | 5.13% |
| Kopernik Global Investors LLCas of 07 Jan 2026 | 4.74m | 4.96% |
| MAK Capital One LLCas of 30 May 2025 | 4.72m | 4.94% |
| Schroder Investment Management Ltd.as of 31 Dec 2025 | 2.75m | 2.88% |
| Niche Asset Management Ltd.as of 30 Jun 2025 | 1.30m | 1.36% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 872.80k | 0.91% |
| EdenTree Investment Management Ltd.as of 30 Jun 2025 | 630.00k | 0.66% |
| Zenito Oyas of 30 Dec 2025 | 500.00k | 0.52% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 492.96k | 0.52% |
| FIAM LLCas of 30 Nov 2025 | 480.86k | 0.50% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
